Effect of pimecrolimus vs. corticosteroids on murine bone marrow-derived dendritic cell differentiation, maturation and function

Experimental Dermatology

Volumn 15, Issue 1, 2006, Pages 43-50

  Krummen, Mathias B W ^a   Varga, Georg ^a   Steinert, Meike ^a   Stuetz, Anton ^b   Luger, Thomas A ^a   Grabbe, Stephan ^a,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Novartis Institutes for Biomedical Research   (Austria)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Calcineurin inhibitor; Cell differentiation; Cell maturation; Corticosteroid; Pimecrolimus

Indexed keywords

CLOBETASONE; CORTICOSTEROID; CYTOKINE; MOMETASONE FUROATE; PIMECROLIMUS; PLACEBO; TOLNAFTATE; CLOBETASOL; DRUG DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; MEMBRANE ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREGNANE DERIVATIVE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; DRUG MEGADOSE; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; PHENOTYPE; PHYSIOLOGY; SECRETION; SPLEEN; T LYMPHOCYTE;

ADRENAL CORTEX HORMONES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, SURFACE; BONE MARROW CELLS; CELL DIFFERENTIATION; CLOBETASOL; DENDRITIC CELLS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; PHENOTYPE; PREGNADIENEDIOLS; SPLEEN; T-LYMPHOCYTES; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644878417     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00395.x     Document Type: Article

References (24)

1. Grassberger M, Baumruker T, Enz A et al. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: In vitro pharmacology. Br J Dermatol 1999: 141:264 -273.
2. Akerblom I E, Slater E P, Beato M, Baxter J D, Mellon P L. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science 1988: 241: 350-353.
3. Auphan N, DiDonato J A, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995: 270: 286-290.
4. Scheinman R I, Gualberto A, Jewell C M, Cidlowski J A, Baldwin A S Jr. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol 1995: 15: 943-953.
5. Danielsen M, Northrop J P, Jonklaas J, Ringold G M. Domains of the glucocorticoid receptor involved in specific and nonspecific deoxyribonucleic acid binding, hormone activation, and transcriptional enhancement. Mol Endocrinol 1987: 1: 816-822.
6. Hollenberg S M, Giguere V, Segui P, Evans R M. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 1987: 49: 39-46.
7. Daynes R A, Araneo B A. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989: 19: 2319-2325.
8. Paliogianni F, Ahuja S S, Balow J P, Balow J E, Boumpas D T. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J Immunol 1993: 151: 4081-4089.
9. Piemonti L, Monti P, Allavena P et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999: 162: 6473-6481.
10. Moser M, De Smedt T, Sornasse T et al. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol 1995: 25: 2818-2824.
11. Russo-Marie F. Macrophages and the glucocorticoids. J Neuroimmunol 1992: 40: 281-286.
12. Da Silva J A. Sex hormones and glucocorticoids: Interactions with the immune system. Ann N Y Acad Sci 1999: 876: 102-117.
13. Labeur M S, Roters B, Pers B et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 1999: 162: 168-175.
14. McLellan A D, Kapp M, Eggert A et al. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood 2002: 99: 2084-2093.
15. Billich A, Aschauer H, Aszodi A, Stuetz A. Percutaneous absorption of drugs used in atopic eczema: Pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 2004: 269: 29-35.
16. Cooper M H, Gregory S H, Thomson A W, Fung J J, Starzl T E, Wing E J. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug 'carry-over' effect. Transplant Proc 1991: 23: 2957-2958.
17. Canning M O, Grotenhuis K, de Wit H J, Drexhage H A. Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur J Endocrinol 2000: 143: 687-695.
18. van den Heuvel M M, van Beek N M, Broug-Holub E et al. Glucocorticoids modulate the development of dendritic cells rom blood precursors. Clin Exp Immunol 1999: 115: 577-583.
19. Vieira P L, Kalinski P, Wierenga E A, Kapsenberg M L, de Jong E C. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 1998: 161: 5245-5251.
20. Kalthoff F S, Chung J, Musser P, Stuetz A. Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids. Clin Exp Immunol 2003: 133: 350-359.
21. Hoetzenecker W, Meingassner J G, Ecker R, Stingl G, Stuetz A, Elbe-Burger A. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol 2004: 122: 673-684
22. Hoetzenecker W, Ecker R, Stuetz A, Stingl G, Kopp T, Elbe-Burger A. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. J Allergy Clin Immunol 2005: 115: 1276-1283.
23. Meingassner J G, Kowalsky E, Schwendinger H, Elbe-Burger A, Stutz A. Pimecrolimus does not affect Langerhans cells in murine epidermis. Br J Dermatol 2003: 149: 853-857.
24. Reich K, Hugo S, Middel P, Blaschke V, Heine A, Neumann C. The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-alpha and IL-1beta. Exp Dermatol 2004: 13: 740-747.